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Abstract
Background: we investigated whether two frailty tools predicted mortality among emergency department (ED) patients
referred to internal medicine and how the level of illness acuity influenced any association between frailty and mortality.
Methods: two tools, embedded in a Comprehensive Geriatric Assessment (CGA), were the clinical frailty scale (CFS) and a
57-item deficit accumulation frailty index (FI-CGA). Illness acuity was assessed using the Canadian Triage and Acuity Scale
(CTAS). We examined all-cause 30-day and 6-month mortality and time to death.
Results: in 808 ED patients (mean age ± SD 80.8 ± 8.8, 54.4% female), the mean FI-CGA score was 0.44 ± 0.14, and the
CFS was 5.6 ± 1.6. A minority (307; 38%) were classified as having high acuity (CTAS: 1–2). The 30-day mortality rate
was 17%; this increased to 34% at 6 months. Compared to well patients with low acuity, the risk of 30-day mortality was
22.5 times (95% CI: 9.35–62.12) higher for severely frail patients with high acuity; 53% of people with very severe frailty
(CFS = 8) and high acuity died within 30 days. When acuity was low, the risk for 30-day mortality was significantly higher
only among those with very high levels of frailty (CFS 7–9, FI-CGA > 0.5). When acuity was high, even lower levels of frailty
(CFS 5–6, FI-CGA 0.4–0.5) were associated with higher 30-day mortality.
Conclusions: across levels of frailty, higher acuity increased mortality risk. When acuity was low, the risk was significant only
when the degree of frailty was high, whereas when acuity was high, even lower levels of frailty were associated with greater
mortality risk.
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Key Points
• The frailty index and the Clinical Frailty Scale are strongly associated with mortality, especially in the short term.
• The risk of 30-day mortality is the highest among severely frail patients with high acuity.
• Higher acuity increases mortality risk across levels of frailty.
• When acuity is low, the mortality risk is significant in patients with high levels of frailty.
• When acuity is high, the mortality risk is significant even in lower levels of frailty.
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Introduction
Frailty is a state of increased vulnerability to adverse out-
comes among people of the same age [1, 2]. It is strongly
associated with increased risks of death and of worsen-
ing health status, notably among older patients with acute
medical conditions [3–7]. This relationship is less studied
among patients in the emergency department (ED) setting
[7–10], despite its implications for appropriate care planning
[11, 12].
The increased risk experienced by frail older adults who
are acutely ill comes not just from their frailty, but from
the severity of their illness [7, 13, 14]. Both frailty and
illness acuity can add information about risk [5, 6, 13].
Screening and assessment measures include formal acuity-
based measures (e.g. Emergency Department Medical Early
Warning Score) and a variety of measures of critical illness
in patients admitted to specialized intensive treatment units
(ITUs) [15]. Typically ITU personnel administer the latter,
even in the ED. Laboratory data assembled in a frailty index
have also been employed as an illness acuity measure [5].
The objectives of this study were to examine (i) whether
two frailty tools embedded in a Comprehensive Geriatric
Assessment (CGA) form—the clinical frailty scale (CFS) and
a deficit accumulation frailty index (FI-CGA)—predicted
mortality among acutely ill older patients (65+ years)
referred to internal medicine and (ii), if so, how the level
of illness acuity influenced the association between frailty
and mortality.
Methods
Study design and data
This is a retrospective study of patients (N = 1024) seen in
the ED by one of us (KR) having been referred to internal
medicine; compared against billing records, approximately
65–70% of all such patients are included here. KR supervised
the CGA and the CFS scoring, which were completed for
all patients to assess their health and social status and to
assist with treatment planning (Figure S1 in the Supple-
mentary data). The database was linked to vital statistics
for all-cause mortality data following the CGA assessment.
Mortality data were only available from January 2009 to
December 2017, allowing complete information on 808 ED
patients; 20 patients were included twice—the average time
between the visits was 214 (SD ±328) days (Figure S2 in the
Supplementary data).
Frailty tools
The FI-CGA was constructed using 57 health-related items
(Table S1 in the Supplementary data). The FI-CGA follows
the deficit accumulation approach, which suggests that the
more deficits a person has, the more likely that person is to be
frail [2, 16, 17]. We used the FI-CGA to measure the current
health state of the patient at admission; this chiefly consists in
the items from the right-hand side in the CGA, and all items
on the problem list (Figure S1 in the Supplementary data).
Note that inasmuch as the patients have come to hospital,
at least one new problem was added to each list. For exam-
ple, ‘acute exacerbation of chronic obstructive pulmonary
disease’ could be the reason for referral (RFR) and listed
first, and COPD, as the chronic condition, could be listed
second. That same convention holds for acute exacerbations
of other chronic illnesses that prompt presentation to the
ED. Current worsening is also captured within the CGA
by features such as delirium, recent mobility impairment,
falls, functional decline or incontinence. The FI-CGA scores
were calculated by dividing the summed deficits by the total
number of items. This yields FI-CGA scores that potentially
can range from 0 to 1; higher values indicate greater frailty.
The CGA assessment form includes the CFS (Figure S1
in the Supplementary data; far right columns; one is for
the patient (‘Pt’), and the other is to estimate caregiver
(‘CG’) health). The CFS summarizes the overall level of
fitness or frailty of an older adult at baseline. Originally, the
CFS was introduced to summarize assessment carried out
by physicians from disparate disciplines who had received
at least some notional training in the CGA rubric [18]. It is
employed that way here, after the CGA had been reviewed by
KR as attending physician on the General Internal Medicine-
ED consult service. The CFS is now also commonly used as
a screening tool. That too happened here, in evaluating the
health of the main caregiver; caregivers of patients in long-
term care facilitates are typically scored as CFS = 2. Other-
wise, the CFS is a measure of patients’ pre-admission health
state; for ED patients this, by a convention validated in an
earlier study [19], is 2 weeks prior to admission. The CFS
ranges from 1 to 9, and as with the FI-CGA, higher values
indicate greater frailty (1 = very fit, 2 = well, 3 = managing
well, 4 = very mildly frail (previously ‘apparently vulnera-
ble’), 5 = mildly frail, 6 = moderately frail, 7 = severely frail,
8 = very severely frail and 9 = terminally ill). Category 9 is
assigned for people who are terminally ill. An CFS score of 9
is the only case in which the current state trumps the baseline
state, in that these terminally ill patients might have been
operating at various frailty levels at baseline.
Acuity
We used the Canadian Triage and Acuity Scale (CTAS) to
assess illness acuity [7, 20]. The CTAS is a descriptive 5-point
triage scale, where level 1 is resuscitation, 2 is emergent, 3
is urgent, 4 is less urgent and 5 is non-urgent. Due to small
sample size for people with scores 1 (N = 18), 4 (N = 24) and
5 (N = 2), we grouped patients with CTAS levels 1–2 as high
acuity and those with CTAS level 3–5 as low acuity.
Mortality
The primary outcome variable was all-cause mortality follow-
ing the CGA assessment. We matched participants against
death records from vital statistics; time to death was recorded
in months. For time to death analysis, we used 1-, 2- and
5-year mortality as the outcomes. Given their common use
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Table 1. Characteristics of the patients included in the study
Mean (±SD) N (%) Median IQR Min Max
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Age 80.8 (8.3) 81 13 57 102
Female 455 (56.3)
N medications 6.9 (3.8) 6 5 0 25
N comorbidities 8.8 (3.3) 9 5 1 23
















CFS (1–9) 5.6 (1.6) 5 1 1 9
CFS groups
Fit and well (1–3)a 78 (9.7)
Very mildly frail (4) 113 (13.9)
Mildly frail (5) 218 (26.9)
Moderately frail (6) 207 (25.6)
Severely frail (7) 85 (10.6)
Very severely frail (8) 38 (4.7)
Terminally ill (9) 69 (8.5)
30-day mortality 139 (17.2)
6-month mortality 276 (34.2)
aCombined due to low sample size.
clinically, we also analysed the probability of death within
30 days and within 6 months from the CGA assessment.
Statistical analysis
All analyses were performed in Stata version 15.0 (Stata
Corp., College Station, TX). We report descriptive statistics
as means (SD) and medians (inter quartile range) for con-
tinuous variables and as proportions for categorical variables.
Survival analysis was used to analyse time to death outcomes,
including graphical presentations of survival probabilities
using Kaplan Meier curves and estimation of the multivari-
ate Cox regression model parameters. The assumption of
proportionality of hazards was assessed graphically, with no
evidence of violation (all P > 0.10). We analysed the associ-
ation of the FI-CGA and CFS independently and combined
with the acuity score; we combined the FI-CGA and CFS
scores with acuity, creating 10- and 8-category frailty-acuity
variables, respectively. We used logistic regression models
to analyse the relationship between binary outcomes and
independent variables. We calculated predicted probabilities
at different levels of FI-CGA and CFS using the estimates
from logistic models using the margins command in Stata
[21]. We plotted the predicted probabilities (average pre-
dictive margins) using the marginsplot command in Stata.
The predictive margins were calculated by averaging the
predictions from the fitted models at the fixed values FI-
CGA and CFS for each individual in the sample [21, 22].
Statistical significance was set at P < 0.05 and all tests were
two-sided.
Ethics approval
Individuals whose data are included in the GPID database
have provided written informed consent, or consent has been
obtained from their substitute decision-makers, to allow
their data to be recorded and used for research purposes.
The study protocol was reviewed and approved by the Nova
Scotia Health Authority Research Ethics Board (NSHA-
REB File No. 1022792). Linkages with Nova Scotia Depart-
ment of Health and Wellness datasets were approved by the
NSHA-REB and by the Health Data Nova Scotia (HDNS)
Data Access Committee (File 2017-OAT-001).
Results
The mean (SD) age was 80.8 (8.3) years; 455 patients
(56%) were female (Table 1). Many patients (307; 38%)
were classified as low acuity (CTAS: 1–2); this proportion
was similar across levels of frailty (Tables S2 and S3 in the
Supplementary data). The mean (SD) of FI-CGA was 0.45
(SD: 0.14) with 118 (14.7%) having FI-CGA scores more
1073
M. H. Pulok et al.
Figure 1. 30-day and 6-month mortality rates by CTAS and frailty [CFS (Panel a), FI-CGA (Panel b)]. Note: People with CFS
1–3 and FI-CGA 0–0.02 and 0.6+ were combined due to low sample size
than 0.6. The FI-CGA was normally distributed (Figure S3
in the Supplementary data). Individual ages were weakly but
significantly related to the FI-CGA scores (Figure S5 in the
Supplementary data). The mean (SD) of the CFS was 5.6
(1.6), and 192 (23.7%) of the patients were severely frail
(CFS: 7–9) (Table 1).
Overall, 17% (95% CI: 0.15–0.20) and 34% (95% CI:
0.31–0.38) of the patients died within 30 days and 6 month
of the CGA assessment, respectively. Mortality rates were
higher among people with higher level of frailty and acu-
ity (Figure 1; Figure S6 in the Supplementary data). For
example, among mildly frail patients (CFS 5), 8.6% (95%
CI: 0.05–0.14) of the patients with low acuity (CTAS 3–
5) and 14.3% (95% CI: 0.08–0.24) of those with high
acuity (CTAS 1–2) died within 30 days. Among very severely
frail patients (CFS 8), 33.3% (95% CI: 0.16–0.57) of the
patients with low acuity and 52.9% (95% CI: 0.28–0.76) of
those with high acuity died within 30 days (Figure 1).
When frailty was examined independently, using either
the CFS or the FI-CGA, the probability of mortality
increased with higher levels of frailty (Tables S4 and S5,
Figure S6 and S7 in the Supplementary data) as well as
when combined with acuity (Figure 3). The association
with 30-day mortality was stronger than in the longer term.
For example, the likelihood of 30-day mortality was about
22 (OR: 22.50, 95% CI: 9.35–62.12) times higher for
the severely frail patients with high acuity compared to
well patients with low acuity, while it was 14 (OR: 14.50,
95% CI: 8.32–29.07) times higher for 6-month mortality
(Figure 2). Similarly, the HR was 7.47 (95% CI: 4.75–
11.77) for 1-year mortality, whereas it was 4.73 (95% CI:
3.45–6.48) for 5-year mortality when patients were severely
frail with high acuity (Figure 3).
Acuity also influenced the association of frailty with mor-
tality. When acuity was low, the risk for 30-day mortality
was significant only among those with very high levels of
frailty (CFS 7–9, FI-CGA > 0.5). When acuity was high,
even lower levels of frailty (CFS 5–6, FI-CGA 0.4–0.5) were
associated with a higher risk of 30-day mortality (Figure 2).
The findings were also similar regarding the impact of acu-
ity on the relationship of frailty with 1–5 years mortality
(Figure 3).
Kaplan–Meier analysis showed that age did not much
discriminate survival probability (Figure S8, Panel A in
the Supplementary data), whereas acuity (Figure S8, Panel
B in the Supplementary data) and frailty did (Figure S8,
Panels C and D in the Supplementary data). Severely frail
patients with high acuity had the lowest chances of survival
(Figure 4). For example, the probability of surviving up to
40 months was only about 8% for the patients with FI-
CGA > 0.6 and high acuity and 10% for patients with 7–9
CFS and high acuity (Figure 4).
Discussion
We explored how the severity of acute illness and the degree
of frailty interact and how that interaction might be assessed
by a geriatrician in the initial evaluation of a patient in an
ED setting. The data suggest that a combination of an acu-
ity/severity measure (which can be either at triage/screening
or arising from a CGA) and a frailty measure (potentially
a frailty screen measure, or as here, informed by the CGA)
gives better information than either alone. Here, for the most
part, the risks arising from the two are more than additive.
Importantly, severely–very severely frail patients who are
acutely unwell bear a substantial 30-day mortality rate (of
35–55%).
Frailty and acuity each merit formal consideration in
the stratification of risk. As with the severity of an acute
illness, the degree of frailty matters. A recent report offers
another insight into stratifying risk based on illness severity
and frailty through the use of a frailty index based solely
on routinely gathered laboratory data [5]. Here we extend
some seminal work from Cambridge on the synergy between
illness severity and frailty in increasing risk [6].
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Figure 2. Predicted probabilities and odds ratio for mortality based on acuity and frailty [CFS (Panel a), FI-CGA (Panel b)]. Note:
People with CFS 1–4 and 7–9 and FI-CGA 0–0.03 and 0.6+ were combined due to low sample size; ∗P < 0.05.
The CFS and the baseline information in the CGA allow
a routine means of understanding baseline function. This is
crucial in understanding illness severity, often signalled by
greater 2-week decline in high-order measures such as cog-
nition, mobility and function. Information about baseline
function is also essential to the care plan. Care planning must
consider whether recovery to baseline is first likely and how
that might fit with patient and carer preferences. Exactly how
to optimize data collection and its incorporation into care
planning from the start of the patient’s admission remains
a compelling challenge. For this we are evaluating whether
the Pictorial Fit-Frail Scale [23–25], which is being made
widely available (specifically including to non-geriatricians),
might facilitate the initial assessment of baseline function
from informants.
Our study has important limitations. These are all patients
from a single Canadian tertiary care hospital who were
consulted to internal medicine, when the internist cover-
ing happened to be a geriatrician. About 30–35% of the
patients referred to internal medicine were not included
in the database. The main reasons were patients could not
provide consent and substitute decision-makers were not
available, patients were admitted from long-term care (LTC)
institutions where a modified version of the CGA had already
been completed as part of the LTC records and patients were
seen under regulations of the Adult Protection Act (as adults
in need of protection, who do not have substitute decision-
makers) and a small number who refused consent. Since we
did not have consent for these patients, we could not extract
any demographic or clinical information to compare them
with the patients who were included.
The CFS as used here summarized a CGA; it was not
used as a screening tool. Even so, these data offer some
insight into how the combination of an acuity measure and
a CFS might better predict risk. We are careful here to note
that this is a separate inquiry for which the current study
offers hypotheses, not their tests. All this too we hope to
address in other settings, at a larger scale. For example, it is
a project that might be suited to the Acute Frailty Network
[26]. Similarly, we do not have data on patient status other
than vital status. An important question in many contexts
is not the chance that a given patient will be alive, but the
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Figure 3. Hazard ratios for mortality based on acuity (CTAS) and frailty [CFS (panel a), FI-CGA (panel b)]. Note: People with
CFS 1–4 and 7–9 and FI-CGA 0–0.03 and 0.6+ were combined due to low sample size; ∗P < 0.05.
extent to which acute changes in cognition or function or
mobility are likely to recover in those respects. The across-
the-board decline seen with those high-order functions may
represent an instance of increased cross-correlation, reflect-
ing greater mutual dependence with loss of resilience [27,
28]. These considerations are motivating additional inquires
by our group. Finally, reflecting the real-world nature of
the evidence, we do not have confirmation of the exact
degree of frailty at the baseline state. For the most part, this
information comes from a history given by a knowledgeable
informant. Other designs, such as the DELPHIC study, are
better suited to that [29].
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Figure 4. Survival probability by CTAS and frailty [CFS (panel a), FI-CGA (panel b)]. Note: People with CFS 1–4 scores were
combined due to low sample size, as were those with CFS scores 7–9, and FI-CGA 0–0.03 and 0.6+.
Conclusion
This study has combined the severity of acute illness with
baseline frailty to predict mortality among older ED patients
seen by a geriatrician. Our findings show that both the CFS
and FI-CGA were strongly associated with short-term mor-
tality among older ED patients referred to internal medicine.
We found that higher severity of acute illness increased
mortality risk across the levels of frailty and that when
acuity was high, even lower levels of frailty were associ-
ated with greater mortality risk. Therefore, it is impor-
tant to consider the interaction between frailty and illness
severity to develop treatment plan in acute care. Using
routine laboratory test data, future work should aim to
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refine the assessment of illness acuity for older patients
in ED.
Supplementary Data: Supplementary data mentioned in
the text are available to subscribers in Age and Ageing online.
Acknowledgements: The data (or portions of the data)
used in this paper were made available by Health Data
Nova Scotia of Dalhousie University. Although this research
is based on data obtained from the Nova Scotia Depart-
ment of Health and Wellness, the observations and opinions
expressed are those of the authors and do not represent those
of either Health Data Nova Scotia or the Department of
Health and Wellness.
Declaration of Conflicts of Interest: Kenneth Rockwood
has asserted copyright of the Clinical Frailty Scale through
Dalhousie University. Use is free for research, education or
not-for-profit care. (Users are asked not to change it or
charge for its use.) In addition to academic and hospital
appointments, he is President and Chief Science Officer of
DGI Clinical, which in the last 5 years, has contracts with
pharma and device manufacturers (Baxter, Baxalta, Biogen,
Shire, Hollister, Nutricia, Roche, Otsuka) on individualized
outcome measurement. In 2017 he attended an advisory
board meeting with Lundbeck. He is an Associate Direc-
tor of the Canadian Consortium on Neurodegeneration in
Aging, which is funded by the Canadian Institutes of Health
Research (CAN-137794), with additional funding from the
Alzheimer Society of Canada and several other charities. He
receives research support through grants from the Canadian
Institutes of Health Research, the Canadian Frailty Network,
the Nova Scotia Health Research Foundation, the Nova Sco-
tia Health Authority Research Fund, the Dalhousie Medical
Research Fund as the Kathryn Allen Weldon Professor of
Alzheimer Research and the Fountain Family Innovation
Fund of the QEII Health Science Centre Foundation.
Declaration of Sources of Funding: This study is funded
by the Canadian Frailty Network (CFN), TG2015-24, and
the Nova Scotia Health Research Foundation (NSHRF),
CAT-2016-1101. However, the interpretation and conclu-
sion of this study are those of the authors alone.
References
1. Vaupel JW, Manton KG, Stallard E. The impact of hetero-
geneity in individual frailty on the dynamics of mortality.
Demography 1979; 16: 439–54.
2. Rockwood K, Howlett SE. Age-related deficit accumulation
and the diseases of ageing. Mech Ageing Dev 2019; 180:
107–16.
3. Theou O, Squires E, Mallery K et al. What do we know
about frailty in the acute care setting? A scoping review. BMC
Geriatr 2018; 18: 139.
4. Klausen HH, Petersen J, Bandholm T et al. Association
between routine laboratory tests and long-term mortality
among acutely admitted older medical patients: a cohort
study. BMC Geriatr 2017; 17: 62.
5. Ellis HL, Wan B, Yeung M et al. Complementing chronic
frailty assessment at hospital admission with an electronic
frailty index (FI-Laboratory) comprising routine blood test
results. CMAJ 2020; 192: E3–8.
6. Romero-Ortuno R, Wallis S, Biram R, Keevil V. Clinical
frailty adds to acute illness severity in predicting mortality in
hospitalized older adults: an observational study. Eur J Intern
Med 2016; 35: 24–34.
7. Mowbray F, Brousseau AA, Mercier E, Melady D, Émond M,
Costa AP. Examining the relationship between triage acuity
and frailty to inform the care of older emergency department
patients: findings from a large Canadian multisite cohort
study. Can J Emerg Med 2020; 22: 74–81.
8. Jørgensen R, Brabrand M. Screening of the frail patient in the
emergency department: a systematic review. Eur J Intern Med
2017; 45: 71–3.
9. Hubbard RE, Peel NM, Samanta M, Gray LC, Mitnitski
A, Rockwood K. Frailty status at admission to hospital
predicts multiple adverse outcomes. Age Ageing 2017; 46:
801–6.
10. Brousseau A-A, Dent E, Hubbard R et al. Identification of
older adults with frailty in the emergency department using a
frailty index: results from a multinational study. Age Ageing
2018; 47: 242–8.
11. Theou O, Campbell S, Malone ML, Rockwood K. Older
adults in the emergency department with frailty. Clin Geriatr
Med 2018; 34: 369–86.
12. Murphy A, Briggs S. The accuracy of frailty scoring and uptake
of comprehensive geriatric assessment (CGA) in patients liv-
ing with frailty admitted through the emergency department
(ED) in Wythenshawe hospital. Age Ageing 2020; 49(Supple-
ment 1): i11–3.
13. Chong E, Ho E, Baldevarona-Llego J et al. Frailty in hospi-
talized older adults: comparing different frailty measures in
predicting short- and long-term patient outcomes. J Am Med
Dir Assoc 2018; 19: 450–7.e3.
14. Chua XY, Toh S, Wei K, Teo N, Tang T, Wee SL. Evaluation
of clinical frailty screening in geriatric acute care. J Eval Clin
Pract 2020; 26: 35–41.
15. Muscedere J, Waters B, Varambally A et al. The impact
of frailty on intensive care unit outcomes: a systematic
review and meta-analysis. Intensive Care Med 2017; 43:
1105–22.
16. Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K.
A standard procedure for creating a frailty index. BMC Geriatr
2008; 8: 24.
17. Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of
deficits as a proxy measure of aging. ScientificWorldJournal
2001; 1: 323–36.
18. Rockwood K, Song X, MacKnight C et al. A global clinical
measure of fitness and frailty in elderly people. Can Med Assoc
J 2005; 173: 489–95.
19. Jarrett PG, Rockwood K, Carver D, Stolee P, Cosway S.
Illness presentation in elderly patients. Arch Intern Med 1995;
155: 1060–4.
20. Elkum NB, Barrett C, Al-Omran H. Canadian emergency
department triage and acuity scale: implementation in a ter-
tiary care center in Saudi Arabia. BMC Emerg Med 2011;
11: 3.
1078
The role of illness acuity on the association between frailty and mortality
21. Muller CJ, MacLehose RF. Estimating predicted probabil-
ities from logistic regression: different methods correspond
to different target populations. Int J Epidemiol 2014; 43:
962–70.
22. Cameron AC, Trivedi P. Regression Analysis of Count Data.
Cambridge: Cambridge University Press, 2013.
23. Theou O, Andrew M, Ahip SS et al. The pictorial fit-frail scale:
developing a visual scale to assess frailty. Can Geriatr J 2019;
22: 64–74.
24. McGarrigle L, Squires E, Wallace LMK et al. Investigating
the feasibility and reliability of the pictorial fit-frail scale. Age
Ageing 2019; 48: 832–7.
25. Wallace LMK, McGarrigle L, Rockwood K, Andrew MK,
Theou O. Validation of the pictorial fit-frail scale in a memory
clinic setting. Int Psychogeriatr 2019: 1–10. [Epub ahead of
print 29 September 2019].
26. Conroy S. The acute frailty network—supporting people with
frailty and urgent care needs to get home sooner and healthier.
Futur Health J 2019; 6: 109–9.
27. Rutenberg AD, Mitnitski AB, Farrell SG, Rockwood K. Uni-
fying aging and frailty through complex dynamical networks.
Exp Gerontol 2018; 107: 126–9.
28. Gijzel SMW, Van De Leemput IA, Scheffer M, Roppolo
M, Olde Rikkert MGM, Melis RJF. Dynamical resilience
indicators in time series of self-rated health correspond to
frailty levels in older adults. Journals Gerontol-Ser A Biol Sci
Med Sci 2017; 72: 991–6.
29. Davis D, Richardson S, Hornby J et al. The delirium and
population health informatics cohort study protocol: ascer-
taining the determinants and outcomes from delirium in a
whole population. BMC Geriatr 2018; 18: 45.
Received 3 March 2020; editorial decision 6 April 2020
1079
